三七通舒胶囊对血管性帕金森综合征的疗效观察  

Clinical efficacy of Sanqi Tongshu capsule on vascular parkinsonism

作　　者：肖家平 李鸣 胡仁琳 聂德云 唐志敏 胡琴 黄天志 朱灿敏 

机构地区：[1]武汉市第五医院神经内科,湖北武汉430050

出　　处：《中国实用神经疾病杂志》2017年第18期11-13,109,共4页Chinese Journal of Practical Nervous Diseases

基　　金：武汉市卫计委公共卫生科研项目(WG13C21)

摘　　要：目的观察三七通舒胶囊对血管性帕金森综合征(VP)的疗效。方法选取VP患者97例,随机分为观察组50例和对照组47例。其中观察组予以三七通舒胶囊+常规治疗,疗程为3个月;对照组给予常规治疗。比较2组患者治疗前、后UPDRS、Hoehn-Yahr、ADL、MMSE评分变化;同时记录2组治疗前、后的血脂、血清Hcy、血液黏稠度变化。结果治疗后,观察组与对照组在UPDRS、Hoehn-Yahr下降,ADL、MMSE评分升高,差异有统计学意义(P<0.05);观察组与对照组在血脂、Hcy及血液黏稠度比较均有下降,差异有统计学意义(P<0.05)。结论三七通舒胶囊对VP治疗有益。Objective To investigate the clinical efficacy of Chinese medicine Sanqi Tongshu capsule on patients with vascular parkinsonism.Methods 97 patients with vascular parkinsonism were randomly divided into the observation group(50cases)and the control group(47cases).The observation group was treated with conventional treatment and Sanqi Tongshu capsule for 3months;The control group was given conventional treatment.The scores of UPDRS,Hoehn&Yahr,ADL and MMSE,the changes of blood lipid,Hcy and blood viscosity were compared in 2groups.Results The scores of UPDRS and Hoehn&Yahr significantly decreased,while the scores of ADL and MMSE were significantly increased compared the observation group and the control group(P<0.05);Compared with the changes of blood lipids,Hcy and blood viscosity,there were significance difference in the observation group.Conclusion Sanqi Tongshu capsule is efficacy to vascular parkinsonism.

关 键 词：三七通舒胶囊 血管性帕金森综合征 血清HCY 血液黏稠度 

分 类 号：R742.5[医药卫生—神经病学与精神病学]